Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04435821 · ClinicalTrials.gov registry record · Phase 1
PET/MRI in the Diagnosis of Pediatric Chronic Pain
A Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT04435821: Completed Phase 1 study, sponsored by Stanford University.
NCT04435821 is a Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04435821, a Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
\[18F\]FTC-146 is a sigma-1 receptor detector and is an experimental radiotracer. Several studies have implicated involvement of sigma-1 receptors in generation and perpetuation of chronic pain conditions, while others are investigating anti sigma-1 receptor drugs for treatment of chronic pain. Using \[18F\]-FTC-146 and PET/MRI, we hope to learn what is the best approach to identify the source of pain generation and characterize the disease in pediatric patients with chronic pain.
Interventions
- DRUG [18F]FTC-146
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2020-11-19 |
| Est. Completion | 2024-10-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04435821
The ClinicalTrials.gov registry entry for NCT04435821 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [18F]FTC-146 is the first listed.
NCT04435821 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04435821 about?
NCT04435821 is a clinical study titled "PET/MRI in the Diagnosis of Pediatric Chronic Pain". \[18F\]FTC-146 is a sigma-1 receptor detector and is an experimental radiotracer. Several studies have implicated involvement of sigma-1 receptors in generation and perpetuation of chronic pain conditions, while others are investigating anti sigma-1 receptor drugs for treatment of chronic pain. Usin...
What is the current status of trial NCT04435821?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2020-11-19. Estimated completion is 2024-10-31.
What interventions are being tested in trial NCT04435821?
The interventions under investigation include: [18F]FTC-146 (DRUG).
Who is sponsoring clinical trial NCT04435821?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.